Evogene Ltd. (EVGN) has a consensus analyst rating of Buy, based on 4 analysts covering the stock. Of those, 4 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for EVGN is $3.50, representing a +331.6% upside from the current price of $0.811. Price targets range from a low of $3.50 to a high of $3.50.
